BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Concert Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 6:02 pm Purchase | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BIOTECHNOLOGY VALUE FUND L P | 4,917,774 9.990% | 1,321,017 (+36.73%) | Filing |
| 2021-11-15 4:58 pm Purchase | 2021-11-03 | 13G | Concert Pharmaceuticals, Inc. CNCE | BIOTECHNOLOGY VALUE FUND L P | 3,596,757 9.990% | 3,596,757 (New Position) | Filing |